+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Antibiotic activity against urinary tract infection (UTI) isolates of vancomycin-resistant enterococci (VRE): results from the 2002 North American Vancomycin Resistant Enterococci Susceptibility Study (NAVRESS)



Antibiotic activity against urinary tract infection (UTI) isolates of vancomycin-resistant enterococci (VRE): results from the 2002 North American Vancomycin Resistant Enterococci Susceptibility Study (NAVRESS)



Journal of Antimicrobial ChemoTherapy 52(3): 382-388



Background: The purpose of this study was to assess the prevalence of vancomycin-resistant enterococci (VRE) in urinary isolates in North America, and the activity of various antibiotics against VRE. Materials and methods: Twenty-eight medical centres in the United States and 10 centres in Canada assessed the prevalence of VRE in urinary isolates in 2002. Each study site was asked to collect up to a maximum of 50 consecutive VRE (Enterococcus faecium, Enterococcus faecalis only) urinary isolates. Susceptibility was determined by NCCLS broth microdilution. The prevalence of vanA and vanB resistance genotypes was determined by multiplex PCR. Results: From the 28 US medical centres, a total of 697 VRE (616 (88.4%) E. faecium and 81 (11.6%) E. faecalis) were received. Approximately 75% of all VRE (E. faecium and E. faecalis) isolates demonstrated a VanA phenotype (resistance to both vancomycin and teicoplanin). PCR detection of vanA and vanB resistance determinants showed that the vanA genotype was present in 584 of 697 (83.8%) VRE isolates, whereas 113 (16.2%) isolates possessed the vanB gene. The most active agents were linezoild, nitrofurantoin and chloramphenicol, with 0.3%, 0.6% and 2.4% resistance, respectively. The majority (77.8%) of vancomycin-resistant E. faecium isolates displayed the VanA phenotype, and 538 of these 616 (87.3%) isolates were PCR-positive for vanA; the vanB genotype was detected in 78 (12.7%) isolates. Resistance was lowest with linezolid, chloramphenicol and nitrofurantoin at 0.3%, 0.3% and 0.5%, respectively. Only three genetically indistinguishable vanA-positive E. faecium were isolated from the 10 Canadian medical centres. Conclusion: VRE urinary isolates are common in the United States, are primarily of the vanA genotype and are very susceptible to linezolid, nitrofurantoin and chloramphenicol. In Canada, VRE urinary isolates remain uncommon.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 010183450

Download citation: RISBibTeXText

PMID: 12888592

DOI: 10.1093/jac/dkg352


Related references

Possibility of vancomycin-resistant enterococci transmission from human to broilers, and possibility of using the vancomycin-resistant gram-positive cocci as a model in a screening study of vancomycin-resistant enterococci infection in the broiler chick. Animal Science Journal 77(5): 538-544, 2006

Fosfomycin Susceptibility in Multidrug-Resistant Enterobacteriaceae Species and Vancomycin-Resistant Enterococci Urinary Isolates. Canadian Journal of Hospital Pharmacy 70(5): 368-374, 2017

Risk of vancomycin-resistant enterococci bloodstream infection among patients colonized with vancomycin-resistant enterococci. Brazilian Journal of Infectious Diseases 19(1): 58-61, 2015

The effect of active surveillance for vancomycin-resistant enterococci in high-risk units on vancomycin-resistant enterococci incidence hospital-wide. American Journal of Infection Control 30(1): 40-43, 2002

Potent activity of the lichen antibiotic (+)-usnic acid against clinical isolates of vancomycin-resistant enterococci and methicillin-resistant Staphylococcus aureus. Die Naturwissenschaften 94(6): 465-468, 2007

Risk factors for development of vancomycin-resistant enterococcal bloodstream infection in patients with cancer who are colonized with vancomycin-resistant enterococci. Clinical Infectious Diseases 35(10): 1139-1146, 2002

Nosocomial vancomycin-resistant enterococcal blood stream infection development in oncology patients colonized with vancomycin-resistant enterococci. Clinical Infectious Diseases 31(1): 278, 2000

Prevalence and distribution of VRE (vancomycin resistant enterococci) and VSE (vancomycin susceptible enterococci) strains in the breeding environment. Annals of Agricultural and Environmental Medicine 23(2): 231-236, 2016

In vitro activity of GAR-936, a novel glycylcycline, against vancomycin-resistant enterococci, teicoplanin-resistant coagulase-negative staphylococci and vancomycin-intermediate Staphylococcus aureus. Abstracts of the Interscience Conference on Antimicrobial Agents and Chemotherapy 41: 172-173, 2001

Susceptibility patterns of recent isolates of vancomycin-resistant enterococci. Abstracts of the General Meeting of the American Society for Microbiology 98: 189, 1998

Near absence of vancomycin-resistant enterococci but high carriage rates of quinolone-resistant ampicillin-resistant enterococci among hospitalized patients and nonhospitalized individuals in Sweden. Journal of Clinical Microbiology 37(11): 3509-3513, 1999

Antibiotic resistance patterns of enterococci and occurrence of vancomycin-resistant enterococci in raw minced beef and pork in Germany. Applied and Environmental Microbiology 64(5): 1825-1830, 1998

Vancomycin resistant enterococci species distribution and antibiotic susceptibility. Abstracts of the General Meeting of the American Society for Microbiology 91: 20, 1991

Selective digestive tract decontamination--will it prevent infection with multidrug-resistant gram-negative pathogens but still be applicable in institutions where methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci are endemic?. Clinical Infectious Diseases 43(Suppl. 2): S70, 2006

Saponins increase susceptibility of vancomycin-resistant enterococci to antibiotic compounds. European Journal of Microbiology and Immunology 4(4): 204-212, 2014